These Healthcare stocks are trading higher:
-Immunoprecise Antibodies Ltd (IPA) stock is trading at $12.96, an increase of $7.41, or 134.05%, on high volume. Immunoprecise Antibodies Ltd gets a Sentiment Score of Very Bullish from InvestorsObserver.
-NRX Pharmaceuticals Inc (NRXP) stock is trading at $17.86, a rise of $7.75, or 74.87%, on high volume. Nrx Pharmaceuticals Inc gets a Sentiment Score of Bearish from InvestorsObserver.
-PainReform Ltd (PRFX) stock is trading at $4.13, a rise of $0.99, or 32.64%, on high volume. Painreform Ltd gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $10.00. Painreform Ltd next reports earnings on August 12.
-Universe Pharmaceuticals Inc (UPC) stock is trading at $3.18, a gain of $0.53, or 20.15%, on high volume. Universe Pharmaceuticals Inc gets a Sentiment Score of Bearish from InvestorsObserver.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Seres Therapeutics Inc (MCRB) stock is trading at $8.91, a loss of $11.92, or 57.23%, on high volume. Seres Theraptc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $38.67. Seres Theraptc next reports earnings on July 27.-Jupiter Wellness Inc (JUPW) stock is trading at $2.04, a loss of $0.75, or 26.88%, on high volume. Jupiter Wellness Inc gets a Sentiment Score of Very Bearish from InvestorsObserver.
-TRACON Pharmaceuticals Inc (TCON) stock is trading at $3.75, a drop of $1.18, or 24.04%, on high volume. Tracon Pharma gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $15.25. Tracon Pharma next reports earnings on August 4.
-Finch Therapeutics Group Inc (FNCH) stock is trading at $13.10, a decline of $3, or 18.63%, on high volume. Finch Therapeutics Group Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $29.33. Finch Therapeutics Group Inc next reports earnings on August 12.
